COMMUNIQUÉS West-GlobeNewswire

Ritter Pharmaceuticals Initiates First Pivotal Phase 3 Trial for RP-G28 for the Treatment of Lactose Intolerance

27/06/2018 - 13:00

Conference Call Today - June 27, 2018 at 4:30 p.m. ET LOS ANGELES , June 27, 2018 (GLOBE NEWSWIRE) -- Ritter Pharmaceuticals, Inc. (Nasdaq: RTTR) (“Ritter Pharmaceuticals” or the “Company”), a developer of innovative [...]

Emerald Health Therapeutics Announces Amendment to Pure Sunfarms’ Cultivation License, Substantially Expanding Cannabis Production Area to 225,000 Square Feet

27/06/2018 - 13:00

VANCOUVER, British Columbia, June 27, 2018 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (TSX-V:EMH) (OTCQX:EMHTF) (“Emerald”) and Village Farms International, Inc. (“Village Farms” or the “Company”) (TSX:VFF) ( [...]

Loop Industries announces world’s first integrated waste to Loop™ PET resin manufacturing technology

27/06/2018 - 13:00

Revolutionary new manufacturing process will position Loop to commercialize its Generation II technology and disrupt how PET resin and polyester fiber is recycled and manufactured TERREBONNE, Quebec, June 27, 2018 ( [...]

Cara Therapeutics Reports Positive Top-Line Data from Adaptive Phase 2/3 Trial of I.V. CR845 in Patients Undergoing Abdominal Surgery

27/06/2018 - 13:00

-I.V. CR845 achieved statistical significance for the study’s primary endpoint of pain relief over the 0 to 24-hour (AUC 0-24) period post-surgery for combined surgeries at the 1.0 mcg/kg dose (p=0.032)- -I.V. CR845 [...]

Revive Therapeutics Announces FDA Grants Orphan Drug Designation for Cannabidiol in the Treatment of Autoimmune Hepatitis

27/06/2018 - 13:00

TORONTO, June 27, 2018 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (TSX VENTURE:RVV) (OTCQB:RVVTF) (FSE:31R) ("Revive" or the "Company") , a company focused on the research, development and commercialization of novel [...]

Summit Announces PhaseOut DMD Did Not Meet Primary Endpoint

27/06/2018 - 13:00

Ezutromid Development to be Discontinued Summit to Focus on Advancing its Pipeline of New Mechanism Antibiotics Conference Call Scheduled for 8:00am EDT / 1:00pm BST OXFORD, United Kingdom and CAMBRIDGE, Mass., June 27 [...]

Avivagen Receives Approval from Health Canada for Use of OxC-beta™ in Companion Animal Supplements

27/06/2018 - 12:30

OTTAWA, Ontario, June 27, 2018 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (“Avivagen” or the “Corporation”), a life sciences corporation focused on developing and commercializing products for livestock, companion [...]

Aquinox Announces Topline Results of Phase 3 LEADERSHIP 301 Clinical Trial in Interstitial Cystitis/Bladder Pain Syndrome

27/06/2018 - 12:30

VANCOUVER, British Columbia, June 27, 2018 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals , Inc. (" Aquinox ") (NASDAQ:AQXP), today announced that the Phase 3 LEADERSHIP 301 clinical trial evaluating once-daily, oral [...]

Healthwise Names Dr. Adam Husney President

27/06/2018 - 12:00

BOISE, Idaho, June 27, 2018 (GLOBE NEWSWIRE) -- Healthwise, a leader in evidence-based health education, technology, and services, announced today that Adam Husney, MD, has been named President of Healthwise, effective [...]

iTeos Therapeutics Expands Board of Directors with the Appointment of David Hallal as Chairman and Tim Van Hauwermeiren as an Independent Director

27/06/2018 - 12:00

iTeos Therapeutics Expands Board of Directors with the Appointment of David Hallal as Chairman and Tim Van Hauwermeiren as an Independent Director Two new appointments follow oversubscribed $75 million (€64 million) [...]

PotNetwork Holdings, Inc. Initiates Corporate Name Change to BioTech Hemp, Inc.

27/06/2018 - 12:00

Company to Change Name for Closer Alignment with its Corporate Identity as a Dominant Player in the CBD Industry FT. LAUDERDALE, Fla., June 27, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- PotNetwork Holdings, Inc. (OTC [...]

Shire plc : Rule 2.9 announcement

27/06/2018 - 08:00

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 27 June 2018 Shire [...]

Dividend payment ex-date of AS “Latvijas Jūras medicīnas centrs”

27/06/2018 - 07:52

Latvia, 2018-06-27 07:52 CEST (GLOBE NEWSWIRE) -- AS “Latvijas Jūras medicīnas centrs” (LJM1R, ISIN code LV0000100741) will close the list of shareholders for dividend payment on July 2, 2018 at the end of the working [...]

ThromboGenics Plans Name Change to "Oxurion"

27/06/2018 - 07:31

To better reflect Company's activities and ambition to deliver best in class therapies for back of the eye disorders Press release - Regulated Information Leuven, Belgium, 27 June 2018 - ThromboGenics NV (Euronext [...]

MDxHealth's SelectMDx Test Successfully Stratifies Men

27/06/2018 - 07:01

NEWS RELEASE MDxHealth's SelectMDx Test Successfully Stratifies Men Who May Benefit from mp-MRI Multiple SelectMDx Clinical Study Abstracts presented at 2018 Global Prostate Congress in Frankfurt, Germany HERSTAL, [...]

Le test SelectMDx de MDxHealth classe avec succès les hommes

27/06/2018 - 07:01

COMMUNIQUÉ DE PRESSE Le test SelectMDx de MDxHealth classe avec succès les hommes qui peuvent bénéficier de l'IRMmp De nombreux résumés d'étude clinique de SelectMDx présentés au congrès mondial sur le cancer de la [...]

Biocartis Group NV: Study Reviewing 2,500 Performed Idylla(TM) Tests Shows Generation of Valid Results in 98.1% of Cases and Outperformance over Reference Methods

27/06/2018 - 07:00

PRESS RELEASE : 27 June 2018, 07:00 CEST Study Reviewing 2,500 Performed Idylla(TM) Tests Shows Generation of Valid Results in 98.1% of Cases and Outperformance over Reference Methods Mechelen, Belgium, 27 June 2018 - [...]

iTeos Therapeutics Expands Board of Directors with the Appointment of David Hallal as Chairman and Tim Van Hauwermeiren as an Independent Director

27/06/2018 - 07:00

iTeos Therapeutics Expands Board of Directors with the Appointment of David Hallal as Chairman and Tim Van Hauwermeiren as an Independent Director Two new appointments follow oversubscribed $75 million (€64 million) [...]

Assure Holdings Corp. Announces Update

27/06/2018 - 05:55

DENVER, June 26, 2018 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “ Company ” or “ Assure ”) (TSXV:IOM) (OTCQB:ARHH) is providing an update relating to the Management Cease Trade Order (“ MCTO ”), effective May 1, [...]